Petragen

Petragen develops precision, disease-modifying therapeutics focused on skeletal mineralization disorders. The company targets significant global unmet needs within this therapeutic area. Their work aims to improve outcomes for patients suffering from debilitating bone-related diseases.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Petragen develops precision, disease-modifying therapeutics focused on skeletal mineralization disorders. The company targets significant global unmet needs within this therapeutic area. Their work aims to improve outcomes for patients suffering from debilitating bone-related diseases.